Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Aldosterone Antagonism in the Reduction of Albuminuria and Diastolic Disfunction of Patients With Diabetic Nephropathy.

NCT00870402 is registered in ClinicalTrials.gov with Universidad de los Andes, Chile as lead sponsor.

NCT NCT00870402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00870402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Aldosterone Antagonism in the Reduction of Albuminuria and Diastolic Disfunction of Patients With Diabetic Nephropathy.
Lead sponsor
Universidad de los Andes, Chile
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2009
Completion date
March 31, 2010
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy